-
In the future, where is the outlet for the development of the pharmaceutical and health industry?
Time of Update: 2021-10-10
According to data from the China Business Industry Research Institute, the size of China's pharmaceutical e-commerce market has increased from 95 billion yuan in 2016 to 199.
The China Business Industry Research Institute predicts that in 2021, the pharmaceutical e-commerce market under the B2B model in my country will reach 258.
-
The evaluation threshold is raised! CDE releases important guiding principles for crystal form research, APIs, preparations...
Time of Update: 2021-10-10
Interpretation: Whether solid drugs need to be controlled and in-depth crystal form research, the core is based on the data results of bioavailability and bioequivalence, "causes" and "effects" should be distinguished; at the same time, liquid preparations are also If the crystal form is to be studied, it cannot be considered that it is finally dissolved and used, so certain research is not carried out .
-
Xinlitai "strikes" innovative drugs!
Time of Update: 2021-10-10
Sales of terminal GLP-1 agonists in public medical institutions in China (unit: ten thousand yuan)Source: Mi Nei. com, China's public medical institutions terminal competition patternIn recent years, license-in (authorized introduction) transactions in the domestic pharmaceutical market have been hot, and local pharmaceutical companies have taken this to quickly enter the innovative drug track and enrich their pipeline of products under research .
-
New type of decoction pieces or a big outbreak, the equipment industry will have a lot to do
Time of Update: 2021-10-10
The broken-wall decoction pieces break the plant cell wall through modern ultra-fine pulverization technology, and release the effective ingredients of traditional Chinese medicine so that the ingredients can be better absorbed by the human body.
-
2 Qilu Class 1 biological drugs are coming!
Time of Update: 2021-10-10
On September 28, CDE's official website showed that Qilu Pharmaceutical's QLF32004 and QLP31907 injections for class 1 biological drug injections have obtained the implied license of clinical trials and are intended to be used for the treatment of advanced malignant solid tumors and B-cell malignant tumors .
-
With the continued positive development of the pharmaceutical packaging industry, this type of enterprise has a broad market prospect
Time of Update: 2021-10-10
From the perspective of development trends, China is currently continuously introducing and upgrading pharmaceutical packaging equipment and materials, and the entire industry is showing a brand new situation .
-
The State Food and Drug Administration issued technical guidelines for clinical trials of new in vitro diagnostic reagents
Time of Update: 2021-10-10
The plan shall make clear provisions on the type of trial design, selection of comparison methods, selection of subjects, evaluation indicators, statistical analysis methods, sample size estimation and quality control requirements, etc.
-
With the rapid development of innovative drugs, investors are increasingly concerned about whether pharmaceutical companies have the ability to "go global"
Time of Update: 2021-10-10
Analysts said that there are more and more products and clinical trials of innovative drugs in China and the United States, which is a general trend .
-
Syndrome differentiation and treatment, three-in-one system of TCM remote consultation to assist in the diagnosis and treatment of new coronary cases in Fujian
Time of Update: 2021-10-10
Chinanews At the scene, Li Candong, President of Fujian University of Traditional Chinese Medicine, Lin Haibin, Secretary of the Party Committee of the Affiliated Hospital of Putian University, relevant persons in charge of the Third People's Hospital Affiliated to Fujian University of Traditional Chinese Medicine, and experts from Fujian University of Traditional Chinese Medicine, Fujian Traditional Chinese Medicine Anti-epidemic Aid Medical Team, and Affiliated Hospital of Putian University Attend the consultation .
-
Hengrui counterattacks Yangtze River!
Time of Update: 2021-10-10
Can Hengrui take this advantage to return to its high position?Picture 1: Hengrui's latest product declarationSource: CDE official websiteFigure 2: Changes in the share of dexmedetomidine hydrochloride injection TOP3 companiesSource: Mi Nei. com, China's public medical institutions terminal competition patternDexmedetomidine is an α2 adrenergic receptor agonist, mainly used for tracheal intubation and sedation during mechanical ventilation in patients undergoing general anesthesia .
-
Will taking antihypertensive drugs be resistant?
Time of Update: 2021-10-10
The blood pressure control of a certain drug is related to the patient's age, compliance, eating habits and other factors .
-
Three generations of old, middle-aged and youth relay race against the virus to lead the way for students
Time of Update: 2021-10-09
The first batch of Huang Danian-style teachers at Fudan University in China: Three generations of old, middle-aged and youth relay race against the virus to lead the way for students T
-
Notice on Public Solicitation of Opinions on the "Technical Guidelines for the Research on the Uniformity of Oral Solid Preparations and the Uniformity of Controlled Dosage Units (Draft for Solicitation of Comments)"
Time of Update: 2021-10-09
pdf 3 "Technical Guidelines for the Research on the Uniformity of Oral Solid Preparations and the Uniformity of Controlled Dosage Units (Draft for Solicitation of Comments)" feedback form.
-
WHO: A total of 231,551,680 confirmed cases of new crowns worldwide
Time of Update: 2021-10-09
WHO: The global cumulative number of confirmed cases of new crown reached 231551680 WHO: The global cumulative number of confirmed cases of new crown reaches 231551680 WHO: The glob
-
From 8 to 5, why did he win the Nobel Prize when he was 54 when he used a dumb method?
Time of Update: 2021-10-09
On October 4, Beijing time, David Julius and Ardem Patapoutian were awarded the 2021 Nobel Prize in Physiology or Medicine for discovering temperature and tactile receptors .
-
Virus traceability is more than "difficult"!
Time of Update: 2021-10-09
October 1, China Ke Xueyuan Academy of Sciences , Chinese Center for Disease Control of the main Rengao Fu team, Beijing University of Chemical Technology Tong Yi Gang team in the "Lancet" international top Journal issued a document review traceable history at the same time, pointed out that the new crown virus traceability is a " Protracted war" requires time, international resources and cooperation .
-
In the first half of the year, the performance of the Chinese medicine sector was excellent, and the second half of the year continued to be optimistic
Time of Update: 2021-10-09
The industry believes that the outstanding performance of the Chinese medicine sector in the first half of the year was mainly due to the fact that frequent favorable policies + consumption attributes + valuation advantages constitute industry opportunities .
-
Can the immunity induced by the virus strain prevent the infection of the mutant strain at the beginning of the epidemic?
Time of Update: 2021-10-09
An American research team conducted experiments using rhesus monkeys to show that the natural immunity induced by the strains isolated in the early stage of the new crown epidemic has a certain effect on preventing the infection of alpha and beta mutant strains, but it is not enough to completely prevent these two mutant strains.
-
Well-known U.S. reporter denounces U.S. media for deliberately promoting the leak of the new coronavirus laboratory
Time of Update: 2021-10-09
The mainstream media in the United States still deliberately guide public opinion and push people to believe in the "laboratory leak theory" despite the fact that a large number of scientific research results have proved the natural origin of the new coronavirus .
-
Health Commission: 22 new cases were diagnosed on the 29th, including 6 from the local area
Time of Update: 2021-10-09
As of 24:00 on September 29, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are currently 908 confirmed cases (including 4 severe cases), a total of 90,584 cured and discharged cases, and a total of 4,636 deaths.
